Jul 9 |
Why Mainz Biomed Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket
|
Jul 9 |
Indivior Provides Business Update; Conference Call at 8:00 AM U.S. EDT
|
Jul 4 |
Pulling back 10% this week, Indivior's LON:INDV) five-year decline in earnings may be coming into investors focus
|
Jul 3 |
Indivior CEO Expects Ongoing U.S. Opioid Crisis to Drive Sales Growth
|
Jun 10 |
Indivior Announces Dosing of First Subject with INDV-2000 in a Phase 2 Study Assessing the Safety and Efficacy of INDV-2000 in Individuals with Opioid Use Disorder
|
May 24 |
With 59% ownership, Indivior PLC (LON:INDV) boasts of strong institutional backing
|
May 23 |
Indivior to Host Analyst Teach-in Event in New York City; Reconfirms Full Year 2024 Guidance
|